GRAM-MANFIY BAKTERIYALI O‘TKIR PNЕVMONIYANI KOMPLЕKS DAVOSIGA GALAVIT DORI MODDASINI KIRITISH SAMARADORLIGI
##article.subject##:
грамотрицательная пневмония, преморбидный фон, дети, иммунитет, галавит##article.abstract##
Hozirgi vaqtda gram-manfiy bakteriyalar bilan kasallanish ayniqsa bolalik davrida dolzarb bo'lib qolmoqda, chunki gram-manfiy bakteriyalar, pnevmoniya, ya'ni atipik pnevmoniya (AP) nafaqat yuqori va pastki nafas yo'llarida o'tkir yallig'lanish jarayonlarining rivojlanishida qo'zg'atuvchining ko'payishi bilan bog'liq, balki ba'zi bemorlarda - tananing va makrofaglarning retikulohistotsitik tizimida uzoq vaqt davomida hujayra ichidagi mavjudligi orqali nafas olish tizimining takroriy va surunkali kasalliklarini shakllantiradi. 4 yoshdan 14 yoshgacha bo‘lgan 90 nafar bolaning kuzatuvida past molekular og‘irlikdagi interferon induktori Galavit dorri moddasini premorbid fonda (nafas olish allergiyasi, bronxial astma, tez-tez ARI) yuzaga keladigan, tasdiqlangan o‘tkir respirator gram-manfiy pnevmoniyani kompleks davolashga kiritish samaradorligi aniqlandi. Galavitni qabul qilganlarda febril davrning davomiyligi, intoksikatsiya, nazofarenks va o‘pkada kataral sindrom, bronxial obstruksiya kamaydi va immunitet holati ko‘rsatkichlari yaxshilandi.
Библиографические ссылки
Абдуллаева З. А. и др. Сердечно-Сосудистые Осложнения На Фоне Перенесенного COVID-19 //Central Asian Journal of Medical and Natural Science. – 2022. – Т. 3. – №. 2. – С. 17-21.
Ташкенбаева Э. и др. Маркеры гиперурикемии как фактор риска и предикторы сердечно-сосудистых заболеваний //Журнал проблемы биологии и медицины. – 2016. – №. 2 (87). – С. 191-194.
Элламонов С. Н., Насырова З. А. КЛИНИЧЕСКИЕ И ИНСТРУМЕНТАЛЬНЫЕ ОСОБЕННОСТИ ТЕЧЕНИЯ ИШЕМИЧЕСКОЙ БОЛЕЗНИ СЕРДЦА У БОЛЬНЫХ C КОМОРБИДНЫМИ СОСТОЯНИЯМИ //Журнал кардиореспираторных исследований. – 2022. – Т. 3. – №. 1.
Mayboroda Yu. N., Markina T. V., Uryaseva E. V. Evaluation of the effectiveness of the Galavit immunomodulator in the treatment of exacerbated catarrhal gingivitis // Medical Bulletin of the North Caucasus. No. 3 (27) 2012
Studentsov E. P., Ramsh S. M. et al. Adaptogens and related groups of drugs - 50 years of research / Reviews of clinical pharmacology and drug therapy / / Volume 11/2013/4
Gaynes R, Edwards JR (2015) Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 41:848–854
Ego A, Preizer JK, Vincent JL. Influence of diagnostic criteria on the incidence of ventilator-associated pneumonia. Breast. 2015; 147:347-355. doi: 10.1378/l.14-0610.
Stevens JP, Kachniarts B, Wright SB, Gillis J, Thalmor D, Clardy P, et al. When the policy is right: variability in diagnoses of ventilator-associated pneumonia in US hospitals. Crete Care Med. 2014;42:497–503. doi: 10.1097/CCM.0b013e3182a66903
Niederman M.S., Chastr J., Corkery K., Fink J.B., Lute S.E., Garcia M.S. BAY41-6551 achieves bactericidal concentrations of amikacin in tracheal aspirate from ventilated Gram-negative pneumonia patients. Intensive Care Med. 2012; 38:263–271. doi: 10.1007/s00134-011-2420-0.
